你好,请登录   免费注册    |    收藏本站
联系电话: 0574-87917803
联系电话: call_new 0574-87917803
HCC2935
HCC2935
规格:
货期:
编号:TS209441
品牌:Testobio
产品名称: HCC2935
商品货号: TS209441
Organism: Homo sapiens, human
Tissue: lung: pleural effusion
Cell Type: epithelial
Product Format: frozen
Morphology: epithelial
Culture Properties: adherent
Biosafety Level: 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease: adenocarcinoma
Age: 39 years
Gender: male
Ethnicity: Caucasian
Storage Conditions: liquid nitrogen vapor phase
Images:
Derivation:

Established from pleural effusion cells of an adenocarcinoma patient who had never smoked.

Clinical Data:
39 years
Caucasian
male
Comments:
This lung adenocarcinoma has an acquired mutation in the EGFR tyrosine kinase domain (E746 - T751 deletion, S752I).
Complete Growth Medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%.
Subculturing: Volumes used in this protocol are for 75cm2 flask; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes.
  1. Remove and discard culture medium.
  2. Briefly rinse the cell layer with or 0.25% (w/v) Trypsin - 0.53 mM EDTA solution or Dulbeccox92s Phosphate Buffered Saline (D-PBS) to remove all traces of serum that contains trypsin inhibitor.
  3. Add 1.0 to 3.0 mL of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until the cell layer is dispersed (usually within 5 to 15 minutes).
    Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
  4. Add 6.0 to 8.0 mL of complete growth medium and aspirate cells by gently pipetting.
  5. Transfer cell suspension to centrifuge tube and spin at approximately 125 x g for 5 to 10 minutes.
  6. Discard supernatant and resuspend cells in fresh growth medium.
  7. Add appropriate aliquots of cell suspension to new culture vessels. An inoculum of 5 x 103 to 7 x 103 viable cells/cm2 is recommended.
  8. Place culture vessels in incubators at 37°C. Maintain cultures at a cell concentration between 8 x 104 and 1 x 105 cells/cm2

Subcultivation Ratio: A subcultivation ratio of 1:4 to 1:6 is recommended
Medium Renewal: Every 2 to 3 days
Cryopreservation:
Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
Storage temperature: liquid nitrogen vapor phase
Culture Conditions:
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Temperature: 37°C
STR Profile:
Amelogenin: X,Y
CSF1PO: 12
D13S317: 12
D16S539: 12
D5S818: 13
D7S820: 12,13
THO1: 7,9
TPOX: 8
vWA: 17
Population Doubling Time: 105 hours
Name of Depositor: JD Minna, AF Gazdar
Deposited As: Homo sapiens
Year of Origin: May 13, 1999
首页 > 产品中心 > 微生物培养 > 菌株 > null > HCC2935

HCC2935

  • 货号: TS209441
  • 好评
询价
  • 品牌 : TESTOBIO
产品名称: HCC2935
商品货号: TS209441
Organism: Homo sapiens, human
Tissue: lung: pleural effusion
Cell Type: epithelial
Product Format: frozen
Morphology: epithelial
Culture Properties: adherent
Biosafety Level: 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease: adenocarcinoma
Age: 39 years
Gender: male
Ethnicity: Caucasian
Storage Conditions: liquid nitrogen vapor phase
Images:
Derivation:

Established from pleural effusion cells of an adenocarcinoma patient who had never smoked.

Clinical Data:
39 years
Caucasian
male
Comments:
This lung adenocarcinoma has an acquired mutation in the EGFR tyrosine kinase domain (E746 - T751 deletion, S752I).
Complete Growth Medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%.
Subculturing: Volumes used in this protocol are for 75cm2 flask; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes.
  1. Remove and discard culture medium.
  2. Briefly rinse the cell layer with or 0.25% (w/v) Trypsin - 0.53 mM EDTA solution or Dulbeccox92s Phosphate Buffered Saline (D-PBS) to remove all traces of serum that contains trypsin inhibitor.
  3. Add 1.0 to 3.0 mL of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until the cell layer is dispersed (usually within 5 to 15 minutes).
    Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
  4. Add 6.0 to 8.0 mL of complete growth medium and aspirate cells by gently pipetting.
  5. Transfer cell suspension to centrifuge tube and spin at approximately 125 x g for 5 to 10 minutes.
  6. Discard supernatant and resuspend cells in fresh growth medium.
  7. Add appropriate aliquots of cell suspension to new culture vessels. An inoculum of 5 x 103 to 7 x 103 viable cells/cm2 is recommended.
  8. Place culture vessels in incubators at 37°C. Maintain cultures at a cell concentration between 8 x 104 and 1 x 105 cells/cm2

Subcultivation Ratio: A subcultivation ratio of 1:4 to 1:6 is recommended
Medium Renewal: Every 2 to 3 days
Cryopreservation:
Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
Storage temperature: liquid nitrogen vapor phase
Culture Conditions:
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Temperature: 37°C
STR Profile:
Amelogenin: X,Y
CSF1PO: 12
D13S317: 12
D16S539: 12
D5S818: 13
D7S820: 12,13
THO1: 7,9
TPOX: 8
vWA: 17
Population Doubling Time: 105 hours
Name of Depositor: JD Minna, AF Gazdar
Deposited As: Homo sapiens
Year of Origin: May 13, 1999
合作单位: